geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 34632

Chapter 34632 provides bibliographic information on scholary research in geography and in the life sciences.



Compost spreader. Official Gazette of the United States Patent & Trademark Office Patents 1280(3), Mar 16

Compost tea system. Official Gazette of the United States Patent & Trademark Office Patents 1276(3), Nov 18

Compost, silage, solar heating apparatus. Official Gazette of the United States Patent & Trademark Office Patents 1245(4), Apr 24

Compost-mediated shifts in plant-associated bacterial communities monitored by PCR-DGGE analysis. Abstracts of the General Meeting of the American Society for Microbiology 103: N-136

Composted amendments alter soil microbial communities and suppress southern blight. Phytopathology 92(6 Supplement): S49, June

Composted green waste as a substitute for peat in growing media. Irish Journal of Agricultural & Food Research 39(3): 465, December

Composting accelerator. Official Gazette of the United States Patent & Trademark Office Patents 1262(2), Sep 10

Composting arrangement. Official Gazette of the United States Patent & Trademark Office Patents 1254(1), Jan 1

Composting as a means of disposal of sheep mortalities. Canadian Journal of Animal Science 79(4): 576, Dec

Composting conditions preventing the development of odorous compounds. Insam, H [Editor], Riddech, N [Editor], Klammer, S [Editor] Microbiology of composting 551-560

Composting container. Official Gazette of the United States Patent & Trademark Office Patents 1221(3), 19-JUL-99

Composting device with internal aeration tube. Official Gazette of the United States Patent & Trademark Office Patents 1264(3), Nov 19

Composting feedlot and dairy manure as a manure management alternative Compost characteristics, crop yields, and nutrient recoveries. Journal of Animal Science 79(Supplement 2): 86-87

Composting in the framework of the EU landfill directive. Insam, H [Editor], Riddech, N [Editor], Klammer, S [Editor] Microbiology of composting 473-486

Composting integral to public garden. Biocycle: 1, 30-33

Composting method for agricultural animal manure. Official Gazette of the United States Patent & Trademark Office Patents 1254(5), Jan 29

Composting nuisance mayflies for sanitary disposal. IAGLR Conference Program & Abstracts 43: A - 148

Composting of Posidonia oceanica and its use in agriculture. Insam, H [Editor], Riddech, N [Editor], Klammer, S [Editor] Microbiology of composting 425-434

Composting of different horticultural wastes Effect of fungal inoculation. Insam, H , Riddech, N , Klammer, S Microbiology of composting 119-132

Composting plant for organic waste and method for composting such waste. Official Gazette of the United States Patent & Trademark Office Patents 1225(4), Aug 24

Composting structure. Official Gazette of the United States Patent & Trademark Office Patents 1261(4), Aug 27

Composting system. Official Gazette of the United States Patent & Trademark Office Patents 1267(4), Feb 25

Compostion, barrier film, and method for preventing contact dermatitis. Official Gazette of the United States Patent & Trademark Office Patents 1237(5), Aug 29

Compostions comprising viruses and methods for concentrating virus preparations. Official Gazette of the United States Patent & Trademark Office Patents 1269(2), Apr 8

Composts as growing media and nitrogen sources for drip and overhead irrigated bedding plants. Hortscience 36(3): 592, June

Compound 2-amino-3- propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound. Official Gazette of the United States Patent & Trademark Office Patents 1273(4), Aug 26

Compound 338-086-15, a novel peptidergic CRF receptor subtype 2 antagonist, selectively blocks urocortin-induced inhibition of gastric contractility in anesthetized rats. Society for Neuroscience Abstracts 27(2): 2227

Compound 338-86-15, a novel peptide CRF-R2 antagonist, selectively blocks CRF and stress-induced delayed gastric emptying in rats. Society for Neuroscience Abstracts 27(2): 2226

Compound 35delG/L90P in GJB2 associated with high-frequency, progressive sensorineural hearing loss in a family Possible genotype-phenotype correlation. Genetics in Medicine 4(3): 187, May-June

Compound 48/80 inhibits tissue factor-initiated coagulation. FASEB Journal 13(7): A1496, April 23

Compound A Concentration and CO2 Absorption Capacity Using Amsorb during Low-Flow Sevoflurane Anesthesia a Comparison of Amsorb and Standard Soda Lime. Anesthesiology Abstracts of Scientific Papers Annual Meeting ( ): Abstract No A-82

Compound A Concentration in the Circle Absorber System during Low-Flow Sevoflurane Anesthesia Comparison between Dragersorb Free , Amsorb and Sodasorb II. Anesthesiology Abstracts of Scientific Papers Annual Meeting ( ): Abstract No A-83

Compound A metabolism by renal beta-lyase and detoxication to mercapturic acids during low-flow sevoflurane anesthesia. Anesthesiology (Hagerstown) 91(3A): A403, Sept

Compound A production in dried standard vs potassium hydroxide free Soda Lime. Anesthesiology (Hagerstown) 91(3A): A1169, Sept

Compound A uptake during low-flow sevoflurane anesthesia Comparison with nephrotoxic doses in rats. Anesthesiology (Hagerstown) 91(5): 1267-1278, Nov

Compound Ablation for Myopia Testing the Validity of a New Surgical Strategy. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 2069

Compound B enhances methamphetamine sensitization locomotor and c - Fos expression mapping studies. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 642 11

Compound CCR5 polymorphisms influence R5 HIV infection levels in Langerhans cells Implications for sexual transmission of HIV. Journal of Investigative Dermatology 119(1): 321, July

Compound Cordyceps TCM-700C exhibits potent hepatoprotective capability in animal model. Fitoterapia 81(1): 1-7

Compound Heterozygosity for Haemoglobin S and Haemoglobin E-Saskatoon First Description in a Greek Girl. Blood 100(11): Abstract No 3555, November 16

Compound Muscle Action Potentials of Malignant Hyperthermia Susceptible and Non-Susceptible Human Skeletal Muscles Differ under Repetitive Stimulation In Vivo. Anesthesiology Abstracts of Scientific Papers Annual Meeting ( ): Abstract No A-997

Compound SFTPB 1549CfwdarwGAA and 457delC heterozygosity in severe congenital lung disease and surfactant protein B deficiency. Human Mutation 14(6): 502-509

Compound adjustable ankle foot orthosis brace. Official Gazette of the United States Patent & Trademark Office Patents 1251(3), Oct 16

Compound aescin vs diclofenac in treating acute soft tissue contusion. Zhongguo Xinyao yu Linchuang Zazhi 23(7): 395-397, July

Compound and a novel process for their preparation. Official Gazette of the United States Patent & Trademark Office Patents 1285(5), Aug 31

Compound and its use. Official Gazette of the United States Patent & Trademark Office Patents 1253(4), Dec 25

Compound and method for degrading amino acids. Official Gazette of the United States Patent & Trademark Office Patents 1239(4), Oct 24

Compound and method for minimizing the appearance of cutaneous neoplasms and discolorations. Official Gazette of the United States Patent & Trademark Office Patents 1251(2), Oct 9

Compound and method for the prevention and/or the treatment of allergy. Official Gazette of the United States Patent & Trademark Office Patents 1273(1), Aug 5

Compound and method for the treatment of pain. Official Gazette of the United States Patent & Trademark Office Patents 1286(1), Sep 7

Compound and methods of inhibiting or stimulating presenilin 1 and related pharmaceuticals and diagnostic agents. Official Gazette of the United States Patent & Trademark Office Patents 1275(3), Oct 21

Compound and pharmaceutical composition of antiplasmid effect and the preparation thereof. Official Gazette of the United States Patent & Trademark Office Patents 1284(3), July 20

Compound and process for producing beta-adrenergic receptor agonist. Official Gazette of the United States Patent & Trademark Office Patents 1251(1), Oct 2

Compound as cholinesterase inhibitor and its isolation from fungus sporotrichum species. Official Gazette of the United States Patent & Trademark Office Patents 1284(1), July 6

Compound assay. Official Gazette of the United States Patent & Trademark Office Patents 1277(3), Dec 16

Compound astigmatic myopia or hyperopia correction by laser ablation. Official Gazette of the United States Patent & Trademark Office Patents 1229(1), Dec 7

Compound bend chassis frame for a harvesting machine. Official Gazette of the United States Patent & Trademark Office Patents 1272(2), July 8

Compound bone structure fabricated from allograft tissue. Official Gazette of the United States Patent & Trademark Office Patents 1231(3), Feb 15

Compound capable of introducing at least one molecule into a cell. Official Gazette of the United States Patent & Trademark Office Patents 1274(1), Sep 2

Compound classification by VARSA shape descriptors An approach combining. Abstracts of Papers American Chemical Society 222(1-2): COMP91

Compound conditioning and blocking in Drosophila. Society for Neuroscience Abstracts 25(1-2): 862

Compound curve shaping apparatus and method, and product produced. Official Gazette of the United States Patent & Trademark Office Patents 1231(3), Feb 15

Compound defects in the FRAP locus reduce its efficiency as a tumor suppressor. Proceedings of the American Association for Cancer Research Annual Meeting 44: 833, July

Compound deletion of the rhoGAP C1 and the argenine-vasopressin V2 receptor genes in a patient with nephrogenic diabetes insipidus. Pediatric Nephrology 13(7): C32, Sept

Compound delivery using impulse transients. Official Gazette of the United States Patent & Trademark Office Patents 1247(4), June 26

Compound delivery using rapidly dissolving collagen film. Official Gazette of the United States Patent & Trademark Office Patents 1244(1), Mar 6

Compound feed containing histidine and process for its preparation. Official Gazette of the United States Patent & Trademark Office Patents 1246(3), May 15

Compound for detecting and modulating RNA activity and gene expression. Official Gazette of the United States Patent & Trademark Office Patents 1248(3), July 17

Compound for inhibiting HIV infectivity. Official Gazette of the United States Patent & Trademark Office Patents 1235(2), June 13

Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis. Official Gazette of the United States Patent & Trademark Office Patents 1249(3), Aug 21

Compound for the amelioration of pseudofolliculitis. Official Gazette of the United States Patent & Trademark Office Patents 1246(2), May 8

Compound for the amelioration of pseudofollicultis. Official Gazette of the United States Patent & Trademark Office Patents 1227(3), Oct 19

Compound for the antemortem diagnosis of Alzheimers Disease and in vivo imaging and prevention of amyloid deposition. Official Gazette of the United States Patent & Trademark Office Patents 1238(1), Sep 5

Compound for the treatment of atherosclerotic-thrombotic pathological conditions. Official Gazette of the United States Patent & Trademark Office Patents 1267(4), Feb 25

Compound for treatment of cardiac arrhythmia, synthesis, and methods of use. Official Gazette of the United States Patent & Trademark Office Patents 1239(2), Oct 10

Compound from Tripterygium wilfordii protects isolated glomeruli from increased albumin permeability caused by FSGS serum. Journal of Investigative Medicine 47(7): 236A, Aug

Compound from Tripterygium wilfordii protects isolated glomeruli from increased albumin permeability caused by focal segmental glomerulosclerosis serum. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 692A, September

Compound having antimalarial activity. Official Gazette of the United States Patent & Trademark Office Patents 1280(4), Mar 23

Compound having effect of promoting neuron differentiation. Official Gazette of the United States Patent & Trademark Office Patents 1258(1), May 7

Compound heterozygosity and variable penetrance in SOD1 amyotrophic lateral sclerosis pedigrees. Annals of Neurology 50(4): 553-554

Compound heterozygosity for FGFR3 gene mutations in a family with hypochondroplasia. American Journal of Human Genetics 69(4 Supplement): 306, October

Compound heterozygosity for Fp subunit mutations causes complex II deficiency in a patient with encephalomyopathy. American Journal of Human Genetics 65(4): A427, Oct

Compound heterozygosity for Hb Korle-Bu and Hb E with a 37-kb deletional alpha-thalassemia in Thai patients. Annals of Hematology 81(7): 389-393, July

Compound heterozygosity for Hb S and Hb G-Copenhagen. Hemoglobin 23(4): 379-381

Compound heterozygosity for Hb Spanish Town GlufwdarwVal, Hb S. Hemoglobin 26(2): 185-189, May

Compound heterozygosity for Hb Tacoma ArgfwdarwSer and beta+-thalassemia. Hemoglobin 24(3): 253-257, August

Compound heterozygosity for mutations in the type VII collagen gene results in severe dystrophic epidermolysis bullosa. Journal of Investigative Dermatology 122(3): A38, March

Compound heterozygosity for novel splice site mutations in ITGA6 leads to lethal junctional epidermolysis bullosa with pyloric atresia. Journal of Dermatological Science 34(2): 129, April

Compound heterozygosity for premature termination codon and glycine substitution mutations in the COL7A1 gene in Korean siblings with a moderately severe phenotype of recessive dystrophic epidermolysis bullosa. Journal of Dermatological Science 33(3): 180-183

Compound heterozygosity for silent and dominant glycine substitution mutations in COL7A1 leads to a marked transient intracytoplasmic retention of procollagen VII and a moderately severe dystrophic epidermolysis bullosa phenotype. Journal of Investigative Dermatology 113(3): 419-421

Compound heterozygosity for the 532-BP deletion beta thalassemia and hereditary persistence of fetal hemoglobin -2 associated with thalassemia intermedia and extramedullary hematopoiesis. Blood 94(10 SUPPL 1 PART 2): 35b, Nov 15

Compound heterozygosity for triplicated alpha-globin gene and alpha-globin gene deletion Implication for thalassaemia screening. British Journal of Haematology 110(2): 498-499, August

Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor in congenital amegakaryocytic thrombocytopenia. Human Genetics 107(3): 225-233, September

Compound heterozygosity for two new mutations in the beta-globin gene and polyadenylation site leads to Thalassemia intermedia in a Tunisian patient. Hemoglobin 28(3): 243-248

Compound heterozygosity in SCN5A drastically impairs sodium channel function and causes severe cardiac conduction disturbances A genetic and functional analysis. Circulation 104(17 Supplement): II 160, October 23

Compound heterozygosity of AE1 genes cause recessive distal renal tubular acidosis in Southeast Asian ovalocytosis. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 444A, Sept

Compound heterozygosity of Crigler-Najjar-type and Gilbert-type mutations resulting in severe neonatal jaundice and kernicterus. Hepatology 30(4 PART 2): 321A, Oct

Compound heterozygosity of TGM1 mutations leads to non-bullous congenital ichthyosiform erythroderma with reduced transglutaminase activity. Journal of Investigative Dermatology 114(4): 826, April

Compound heterozygosity of a one amino-acid insertion/nonsense mutation in the plectin gene associated with autosomal recessive epidermolysis bullosa with muscle involvement. Journal of Investigative Dermatology 112(4): 616, April

Compound heterozygotes of Gilberts and Crigler-Najjar An unusual cause of hyperbilirubinemia. JPGN 31(Supplement 2): S58

Compound heterozygous TGM1 mutations including a novel missense mutation L204Q in a mild form of lamellar ichthyosis. Journal of Investigative Dermatology 116(6): 992-995

Compound heterozygous mutation of Na+/glucose cotransporter gene in a Japanese patient with congenital glucose-galactose malabsorption. Biochemical Society Transactions 28(5): A391, October

Compound heterozygous mutations in KvLQT1 leading to Jervell and Lange-Nielsen Syndrome and sudden cardiac death. Circulation 100(18 SUPPL ): I 495, Nov 2

Compound heterozygous mutations in parkin in a large family with late-onset, tremor-dominant Parkinsons disease of pseudo-dominant inheritance. Neurology 52(6 SUPPL 2): A555, April 12

Compound heterozygous mutations in the hairless gene in atrichia with papular lesions. Journal of Investigative Dermatology 121(2): 430-432

Compound heterozygous mutations in the hairless gene underlie atrichia with papular lesions. Journal of Investigative Dermatology 119(1): 290, July

Compound heterozygous mutations of the AIRE-1 gene causing autoimmune polyendocrinopathy type 1. Journal of Bone & Mineral Research 16(Suppl 1): S303, September

Compound intraocular lens. Official Gazette of the United States Patent & Trademark Office Patents 1227(3), Oct 19

Compound lever activated elastomeric band castration tool. Official Gazette of the United States Patent & Trademark Office Patents 1222(2), 02-AUG-99

Compound library management. Methods in Molecular Biology 190: 117-127

Compound library management. An overview of an automated system. Methods in Molecular Biology 190: 129-152

Compound liquor. Official Gazette of the United States Patent & Trademark Office Patents 1224(1), Jul 6

Compound microsatellite primers for the detection of genetic polymorphisms. Official Gazette of the United States Patent & Trademark Office Patents 1226(3), Sep 21

Compound nesting of Strumigenys sp and Diacamma sp , and other nesting symbioses of myrmicine and ponerine ants in Southeast Asia. Insectes Sociaux 50(1): 88-97

Compound pigmentation Neurofibromatosis type 1 and tuberous sclerosis in a young girl. Pediatric Research 53(4 Part 2): 262A, April

Compound possessing potent thrombin receptor antagonist activity. Official Gazette of the United States Patent & Trademark Office Patents 1259(1), June 4

Compound preparation for the treatment of hypogonadal men and men with hypophyseal diseases. Official Gazette of the United States Patent & Trademark Office Patents 1218(1): 301-302, Jan 5

Compound screening assays using a transgenic mouse model of human skin diseases. Official Gazette of the United States Patent & Trademark Office Patents 1271(2), June 10

Compound screening method. Official Gazette of the United States Patent & Trademark Office Patents 1286(1), Sep 7

Compound screening methods. Official Gazette of the United States Patent & Trademark Office Patents 1269(1), Apr 1

Compound specific delta15Npermill values Amino acids in grassland and arable soils. Soil Biology & Biochemistry 31(12): 1751-1755, Oct

Compound specific isotope analysis as a means of tracing the sources and fates of PCBs in the environment. Abstracts of Papers American Chemical Society 220(Part 1): ENVR 310

Compound specific nitrogen isotope measurements of soil amino acids. Abstracts of Papers American Chemical Society 225(1-2): GEOC 51

Compound spikelets correlate with high-threshold bursting in thalamocortical neurones in vitro. Journal of Physiology (Cambridge) 544P: 76P, November

Compound storage. Official Gazette of the United States Patent & Trademark Office Patents 1274(5), Sep 30

Compound to regulate the morphological transition of dimorphic candida. Official Gazette of the United States Patent & Trademark Office Patents 1249(1), Aug 7

Compound toothpaste and a method of making it. Official Gazette of the United States Patent & Trademark Office Patents 1226(2), Sep 14

Compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same. Official Gazette of the United States Patent & Trademark Office Patents 1284(1), July 6

Compound useful as reversible inhibitors of cysteine proteases. Official Gazette of the United States Patent & Trademark Office Patents 1260(3), July 16

Compound with alpha-glucosidase inhibiting action and method for producing the same. Official Gazette of the United States Patent & Trademark Office Patents 1257(4), Apr 23

Compound with growth hormone releasing properties. Official Gazette of the United States Patent & Trademark Office Patents 1271(2), June 10

Compound, WF002, production thereof and use thereof. Official Gazette of the United States Patent & Trademark Office Patents 1267(3), Feb 18

Compound, composition and method for the treatment of inflammatory and inflammatory-related disorders. Official Gazette of the United States Patent & Trademark Office Patents 1282(3), May 18

Compound, composition and method for treating cancer. Official Gazette of the United States Patent & Trademark Office Patents 1246(4), May 22

Compound-loaded liposomes and methods for their preparation. Official Gazette of the United States Patent & Trademark Office Patents 1237(5), Aug 29

Compound-specific activation of signal transduction pathways by two 5-HT4 receptor splice variants expressed in HEK293 cells. Society for Neuroscience Abstracts 25(1-2): 1206

Compound-specific isotope tracing of organic compounds from dung in temperate grassland soil. Abstracts of Papers American Chemical Society 225(1-2): GEOC 98

Compound-specific stable isotope approaches to the investigation of carbon cycling in soils. Abstracts of Papers American Chemical Society 225(1-2): GEOC 36

Compounding method for reducing speckle noise. Official Gazette of the United States Patent & Trademark Office Patents 1267(2), Feb 11

Compounds. Official Gazette of the United States Patent & Trademark Office Patents 1237(2), Aug 8

Compounds. Official Gazette of the United States Patent & Trademark Office Patents 1248(5), July 31

Compounds . Official Gazette of the United States Patent & Trademark Office Patents 1255(4), Feb 26

Compounds. Official Gazette of the United States Patent & Trademark Office Patents 1271(3), June 17

Compounds. Official Gazette of the United States Patent & Trademark Office Patents 1282(2), May 11

Compounds a containing a solid support. Official Gazette of the United States Patent & Trademark Office Patents 1223(3), Jun 15

Compounds activating pharmacological effect of retinoids. Official Gazette of the United States Patent & Trademark Office Patents 1238(3), Sep 19

Compounds activating pharmacological effects of retinoids. Official Gazette of the United States Patent & Trademark Office Patents 1224(4), Jul 27

Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases. Official Gazette of the United States Patent & Trademark Office Patents 1230(4), Jan 25

Compounds affecting cholesterol absorption. Official Gazette of the United States Patent & Trademark Office Patents 1281(4), Apr 27

Compounds alkylating specific base sequence of DNA and method for synthesizing the same. Official Gazette of the United States Patent & Trademark Office Patents 1270(3), May 20

Compounds and compositions as anticoagulants. Official Gazette of the United States Patent & Trademark Office Patents 1240(3), Nov 21

Compounds and compositions as cathepsin S inhibitors. Official Gazette of the United States Patent & Trademark Office Patents 1265(2), Dec 10

Compounds and compositions as protease inhibitors. Official Gazette of the United States Patent & Trademark Office Patents 1267(4), Feb 25

Compounds and compositions for delivering active agents. Official Gazette of the United States Patent & Trademark Office Patents 1234(2), May 9

Compounds and compositions for delivering active agents. Official Gazette of the United States Patent & Trademark Office Patents 1247(1), June 5

Compounds and compositions for delivering active agents. Official Gazette of the United States Patent & Trademark Office Patents 1256(3), Mar 19

Compounds and compositions for delivering active agents. Official Gazette of the United States Patent & Trademark Office Patents 1279(3), Feb 17

Compounds and compositions for treating C1s-mediated diseases and conditions. Official Gazette of the United States Patent & Trademark Office Patents 1267(1), Feb 4

Compounds and compositions for treating tissue ischemia. Official Gazette of the United States Patent & Trademark Office Patents 1258(3), May 21

Compounds and compositions with nitrogen-containing non-basic side chains. Official Gazette of the United States Patent & Trademark Office Patents 1262(1), Sep 3

Compounds and method for inhibiting MRP1. Official Gazette of the United States Patent & Trademark Office Patents 1277(5), Dec 30

Compounds and method for modulating neurite outgrowth. Official Gazette of the United States Patent & Trademark Office Patents 1253(4), Dec 25

Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids. Official Gazette of the United States Patent & Trademark Office Patents 1254(2), Jan 8

Compounds and method for the prevention and treatment of diabetic retinopathy. Official Gazette of the United States Patent & Trademark Office Patents 1261(4), Aug 27

Compounds and method of treating psychosis and schizophrenia. Official Gazette of the United States Patent & Trademark Office Patents 1223(5), Jun 29

Compounds and methods. Official Gazette of the United States Patent & Trademark Office Patents 1259(1), June 4

Compounds and methods and modulating tissue permeability. Official Gazette of the United States Patent & Trademark Office Patents 1247(3), June 19

Compounds and methods for cancer therapy. Official Gazette of the United States Patent & Trademark Office Patents 1260(2), July 9

Compounds and methods for detecting biomolecules. Official Gazette of the United States Patent & Trademark Office Patents 1245(3), Apr 17

Compounds and methods for diagnosing and treating amyloid-related conditions. Official Gazette of the United States Patent & Trademark Office Patents 1272(2), July 8

Compounds and methods for diagnosis of leishmaniasis. Official Gazette of the United States Patent & Trademark Office Patents 1223(3), Jun 15

Compounds and methods for diagnosis of lung cancer. Official Gazette of the United States Patent & Trademark Office Patents 1245(1), Apr 3

Compounds and methods for diagnosis of tuberculosis. Official Gazette of the United States Patent & Trademark Office Patents 1254(3), Jan 15

Compounds and methods for immunotherapy and diagnosis of tuberculosis. Official Gazette of the United States Patent & Trademark Office Patents 1272(3), July 15

Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer. Official Gazette of the United States Patent & Trademark Office Patents 1232(1), Mar 7

Compounds and methods for increasing endogenous levels of corticotropin-releasing factor. Official Gazette of the United States Patent & Trademark Office Patents 1226(4), Sep 28

Compounds and methods for inhibiting cancer metastasis. Official Gazette of the United States Patent & Trademark Office Patents 1261(2), Aug 13

Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin. Official Gazette of the United States Patent & Trademark Office Patents 1269(4), Apr 22

Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2. Official Gazette of the United States Patent & Trademark Office Patents 1265(3), Dec 17

Compounds and methods for modulating OB-cadherin mediated cell adhesion. Official Gazette of the United States Patent & Trademark Office Patents 1263(5), Oct 29

Compounds and methods for modulating activation of NF-kappaB. Official Gazette of the United States Patent & Trademark Office Patents 1277(1), Dec 2

Compounds and methods for modulating adhesion molecule function. Official Gazette of the United States Patent & Trademark Office Patents 1249(3), Aug 21

Compounds and methods for modulating apoptosis. Official Gazette of the United States Patent & Trademark Office Patents 1270(2), May 13

Compounds and methods for modulating beta-catenin mediated gene expression. Official Gazette of the United States Patent & Trademark Office Patents 1251(3), Oct 16

Compounds and methods for modulating cell adhesion. Official Gazette of the United States Patent & Trademark Office Patents 1231(5), Feb 29

Compounds and methods for modulating cell-adhesion mediated drug resistance. Official Gazette of the United States Patent & Trademark Office Patents 1288(1), Nov 2

Compounds and methods for modulating cerebral amyloid angiopathy. Official Gazette of the United States Patent & Trademark Office Patents 1277(5), Dec 30

Compounds and methods for modulating claudin-mediated functions. Official Gazette of the United States Patent & Trademark Office Patents 1283(5), June 29

Compounds and methods for modulating cxcr3 function. Official Gazette of the United States Patent & Trademark Office Patents 1270(1), May 6

Compounds and methods for modulating desmosomal cadherin-mediated functions. Official Gazette of the United States Patent & Trademark Office Patents 1275(4), Oct 28

Compounds and methods for modulating endothelial cell adhesion. Official Gazette of the United States Patent & Trademark Office Patents 1273(4), Aug 26

Compounds and methods for modulating junctional adhesion molecule-mediated functions. Official Gazette of the United States Patent & Trademark Office Patents 1258(3), May 21

Compounds and methods for modulating nonclassical cadherin-mediated functions. Official Gazette of the United States Patent & Trademark Office Patents 1256(3), Mar 19

Compounds and methods for modulating tissue permeability. Official Gazette of the United States Patent & Trademark Office Patents 1237(5), Aug 29

Compounds and methods for modulation of estrogen receptors. Official Gazette of the United States Patent & Trademark Office Patents 1250(3), Sep 18

Compounds and methods for regulating bacterial growth and pathogenesis. Official Gazette of the United States Patent & Trademark Office Patents 1270(1), May 6

Compounds and methods for regulating cell adhesion. Official Gazette of the United States Patent & Trademark Office Patents 1244(3), Mar 20

Compounds and methods for site directed mutations in eukarylotic cells. Official Gazette of the United States Patent & Trademark Office Patents 1219(3): 2481, Feb 16

Compounds and methods for stimulating beta-catenin mediated gene expression and differentiation. Official Gazette of the United States Patent & Trademark Office Patents 1280(3), Mar 16

Compounds and methods for stimulating gene expression and cellular differentiation. Official Gazette of the United States Patent & Trademark Office Patents 1278(4), Jan 27

Compounds and methods for synthesis and therapy. Official Gazette of the United States Patent & Trademark Office Patents 1226(2), Sep 14

Compounds and methods for the detection and prevention of Tcruzi infection. Official Gazette of the United States Patent & Trademark Office Patents 1260(3), July 16

Compounds and methods for the diagnosis and treatment of B microti infection. Official Gazette of the United States Patent & Trademark Office Patents 1243(1), Feb 6

Compounds and methods for the diagnosis and treatment of Babesia microti infection. Official Gazette of the United States Patent & Trademark Office Patents 1245(2), Apr 10

Compounds and methods for the diagnosis and treatment of ehrlichia infection. Official Gazette of the United States Patent & Trademark Office Patents 1278(1), Jan 6

Compounds and methods for the inhibition of protein-protein interactions. Official Gazette of the United States Patent & Trademark Office Patents 1263(3), Oct 15

Compounds and methods for the inhibition of the expression of VCAM-1. Official Gazette of the United States Patent & Trademark Office Patents 1240(2), Nov 14

Compounds and methods for the selective treatment of cancer and bacterial infections. Official Gazette of the United States Patent & Trademark Office Patents 1245(3), Apr 17

Compounds and methods for the stimulation and enhancement of protective immune responses and IL-12 production. Official Gazette of the United States Patent & Trademark Office Patents 1220(1): 482, March 2

Compounds and methods for the treatment and diagnosis of chlamydial infection. Official Gazette of the United States Patent & Trademark Office Patents 1241(4), Dec 26

Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders. Official Gazette of the United States Patent & Trademark Office Patents 1231(3), Feb 15

Compounds and methods for the treatment of inflammatory and immune disorders. Official Gazette of the United States Patent & Trademark Office Patents 1250(4), Sep 25

Compounds and methods for the treatment of neoplastic disease. Official Gazette of the United States Patent & Trademark Office Patents 1287(2), Oct 12

Compounds and methods for the treatment of pain. Official Gazette of the United States Patent & Trademark Office Patents 1282(1), May 4

Compounds and methods for the treatment of post traumatic stress disorder. Official Gazette of the United States Patent & Trademark Office Patents 1264(4), Nov 26

Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetics risk of developing complications and determining the efficacy of therapeutic intervention. Official Gazette of the United States Patent & Trademark Office Patents 1229(3), Dec 21

Compounds and methods for therapy and diagnosis of lung cancer. Official Gazette of the United States Patent & Trademark Office Patents 1264(3), Nov 19

Compounds and methods for therapy of lung cancer. Official Gazette of the United States Patent & Trademark Office Patents 1252(1), Nov 6

Compounds and methods for treating PDE IV-related diseases. Official Gazette of the United States Patent & Trademark Office Patents 1229(1), Dec 7

Compounds and methods for treating mitochondria-associated diseases. Official Gazette of the United States Patent & Trademark Office Patents 1248(5), July 31

Compounds and methods for treating multiple sclerosis. Official Gazette of the United States Patent & Trademark Office Patents 1228(2), Nov 9

Compounds and methods for treating transplant rejection. Official Gazette of the United States Patent & Trademark Office Patents 1277(5), Dec 30

Compounds and methods for treatment and diagnosis of chlamydial infection. Official Gazette of the United States Patent & Trademark Office Patents 1262(2), Sep 10

Compounds and methods for treatment and diagnosis of mycobacterial infections. Official Gazette of the United States Patent & Trademark Office Patents 1228(3), Nov 16

Compounds and methods for treatment of asthma, allergy and inflammatory disorders. Official Gazette of the United States Patent & Trademark Office Patents 1262(3), Sep 17

Compounds and methods for use thereof in the treatment of cancer. Official Gazette of the United States Patent & Trademark Office Patents 1280(4), Mar 23

Compounds and methods of treating cell proliferative diseases. Official Gazette of the United States Patent & Trademark Office Patents 1269(4), Apr 22

Compounds and methods of use for treatment of neurogenic inflammation. Official Gazette of the United States Patent & Trademark Office Patents 1250(3), Sep 18

Compounds and methods of use to treat infectious diseases. Official Gazette of the United States Patent & Trademark Office Patents 1251(1), Oct 2

Compounds and methods to treat cardiac failure and other disorders. Official Gazette of the United States Patent & Trademark Office Patents 1254(4), Jan 22

Compounds and methods which modulate feeding behavior and related diseases. Official Gazette of the United States Patent & Trademark Office Patents 1243(2), Feb 13

Compounds and pharmaceutical compositions containing the same. Official Gazette of the United States Patent & Trademark Office Patents 1247(1), June 5

Compounds and pharmaceutical compositions containing them. Official Gazette of the United States Patent & Trademark Office Patents 1234(2), May 9

Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections. Official Gazette of the United States Patent & Trademark Office Patents 1260(3), July 16

Compounds and pharmaceutical compositions thereof for eliciting analgesic effects. Official Gazette of the United States Patent & Trademark Office Patents 1223(4), Jun 22

Compounds and pharmaceutical use thereof. Official Gazette of the United States Patent & Trademark Office Patents 1230(4), Jan 25

Compounds and related methods for inhibition of gamma-aminobutyric acid aminotransferase. Official Gazette of the United States Patent & Trademark Office Patents 1286(3), Sep 21

Compounds and related methods for modulating potassium ion channels and assays for such compounds. Official Gazette of the United States Patent & Trademark Office Patents 1218(1): 363, Jan 5

Compounds and their combinations for the treatment of influenza infection. Official Gazette of the United States Patent & Trademark Office Patents 1230(2), Jan 11

Compounds and their compositions having anti-inflammatory and anti-thrombotic activities. Official Gazette of the United States Patent & Trademark Office Patents 1232(3), Mar 21

Compounds and their therapeutic use. Official Gazette of the United States Patent & Trademark Office Patents 1283(2), June 8

Compounds and their use. Official Gazette of the United States Patent & Trademark Office Patents 1272(3), July 15

Compounds and their use as PDE inhibitors. Official Gazette of the United States Patent & Trademark Office Patents 1274(2), Sep 9

Compounds and their uses. Official Gazette of the United States Patent & Trademark Office Patents 1284(1), July 6

Compounds and therapeutic methods. Official Gazette of the United States Patent & Trademark Office Patents 1275(2), Oct 14

Compounds and therapies for the prevention of vascular and non-vascular pathologies. Official Gazette of the United States Patent & Trademark Office Patents 1238(2), Sep 12

Compounds and therapy for resisting memory loss in humans. Official Gazette of the United States Patent & Trademark Office Patents 1241(2), Dec 12

Compounds as PDE IV and TNF inhibitors. Official Gazette of the United States Patent & Trademark Office Patents 1263(5), Oct 29

Compounds as delta opioid agonists. Official Gazette of the United States Patent & Trademark Office Patents 1244(2), Mar 13

Compounds as inhibitor of tumor necrosis factor alpha release. Official Gazette of the United States Patent & Trademark Office Patents 1246(5), May 29

Compounds capable of cleaving double-stranded DNA and method of utilization of the same. Official Gazette of the United States Patent & Trademark Office Patents 1280(5), Mar 30

Compounds comprising sulfated nonulonic acid having antiviral activity. Official Gazette of the United States Patent & Trademark Office Patents 1254(2), Jan 8

Compounds consisting in particular of effectors of the central nervous system receptors sensitive excitatory amino acids, preparation and biological applications. Official Gazette of the United States Patent & Trademark Office Patents 1261(2), Aug 13

Compounds containing a Michael-acceptor, especially maleimide or maleic acid derivatives, directly or indirectly linked to a chromophore and their use in long lasting sunscreen compositions. Official Gazette of the United States Patent & Trademark Office Patents 1220(1): 550, March 2

Compounds containing biologically active silicon, which are under solid form. Official Gazette of the United States Patent & Trademark Office Patents 1244(1), Mar 6

Compounds containing boron for energy-filtering transmission electron microscopy and for boron neutron-capture therapy. Official Gazette of the United States Patent & Trademark Office Patents 1267(3), Feb 18

Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group. Official Gazette of the United States Patent & Trademark Office Patents 1248(1), July 3

Compounds derived from 3- oxazolidin-2-one, preparation method therefor and therapeutical use thereof. Official Gazette of the United States Patent & Trademark Office Patents 1240(1), Nov 7

Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme. Official Gazette of the United States Patent & Trademark Office Patents 1259(1), June 4

Compounds derived from benzoic acid esters, composition containing said compounds and use thereof. Official Gazette of the United States Patent & Trademark Office Patents 1273(1), Aug 5

Compounds derived from human bactericidal/permeability increasing protein suppress VEGF-induced retinal endothelial cell growth and hypoxia-induced retinal neovascularization while enhancing retinal pericyte growth. IOVS 42(4): S243, March 15

Compounds derived from menthol and use as refreshing agent. Official Gazette of the United States Patent & Trademark Office Patents 1256(3), Mar 19

Compounds derived from oxazolidin-2-one and preparation and therapeutical use thereof. Official Gazette of the United States Patent & Trademark Office Patents 1224(3), Jul 20

Compounds encoding the protective M-like protein of Streptococcus equi and assays therefor. Official Gazette of the United States Patent & Trademark Office Patents 1263(1), Oct 1

Compounds enhancing antitumor activity of other cytotoxic agents. Official Gazette of the United States Patent & Trademark Office Patents 1239(2), Oct 10

Compounds extracted from Phyllantus and Jatropha elliptica inhibit the binding of [3H]glutamate and [3H]GMP-PNP in rat cerebral cortex membrane. Neurochemical Research 25(2): 211-215

Compounds for altering cell surface sialic acids and methods of use therefor. Official Gazette of the United States Patent & Trademark Office Patents 1249(2), Aug 14

Compounds for altering mitochondrial function and cellular responses. Official Gazette of the United States Patent & Trademark Office Patents 1269(4), Apr 22

Compounds for and methods of inhibiting matrix metalloproteinases. Official Gazette of the United States Patent & Trademark Office Patents 1238(2), Sep 12

Compounds for blocking androgen receptors. Official Gazette of the United States Patent & Trademark Office Patents 1284(4), July 27

Compounds for cancer imaging and therapy. Official Gazette of the United States Patent & Trademark Office Patents 1267(2), Feb 11

Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same. Official Gazette of the United States Patent & Trademark Office Patents 1249(2), Aug 14

Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm. Official Gazette of the United States Patent & Trademark Office Patents 1230(2), Jan 11

Compounds for deactivating phospholamban function on Ca-ATPase. Official Gazette of the United States Patent & Trademark Office Patents 1268(4), Mar 25

Compounds for diagnosis and/or therapy of tumours. Official Gazette of the United States Patent & Trademark Office Patents 1241(1), Dec 5

Compounds for diagnosis of Breast cancer and methods for their use. Official Gazette of the United States Patent & Trademark Office Patents 1257(1), Apr 2

Compounds for diagnosis of tuberculosis and methods for their use. Official Gazette of the United States Patent & Trademark Office Patents 1269(5), Apr 29

Compounds for enhancing chemotherapy. Official Gazette of the United States Patent & Trademark Office Patents 1268(4), Mar 25

Compounds for fluorescence labeling. Official Gazette of the United States Patent & Trademark Office Patents 1286(3), Sep 21

Compounds for generating chemiluminescence with a peroxidase. Official Gazette of the United States Patent & Trademark Office Patents 1279(4), Feb 24

Compounds for immunotherapy and diagnosis of breast cancer and methods for their use. Official Gazette of the United States Patent & Trademark Office Patents 1259(4), June 25

Compounds for immunotherapy and diagnosis of colon cancer and methods for their use. Official Gazette of the United States Patent & Trademark Office Patents 1250(1), Sep 4

Compounds for immunotherapy of breast cancer and methods for their use. Official Gazette of the United States Patent & Trademark Office Patents 1257(5), Apr 30

Compounds for immunotherapy of prostate cancer and methods for their use. Official Gazette of the United States Patent & Trademark Office Patents 1248(3), July 17

Compounds for inhibiting beta-amyloid peptide release and/or its synthesis. Official Gazette of the United States Patent & Trademark Office Patents 1244(4), Mar 27

Compounds for inhibition of ceramide-mediated signal transduction. Official Gazette of the United States Patent & Trademark Office Patents 1252(4), Nov 27

Compounds for inhibition of gastric acid secretion. Official Gazette of the United States Patent & Trademark Office Patents 1248(4), July 24

Compounds for mass spectrometry comprising nucleic acid bases and aryl ether mass markers. Official Gazette of the United States Patent & Trademark Office Patents 1250(2), Sep 11

Compounds for medicinal use. Official Gazette of the United States Patent & Trademark Office Patents 1220(1): 529, March 2

Compounds for modulating cell proliferation. Official Gazette of the United States Patent & Trademark Office Patents 1287(1), Oct 5

Compounds for preparing modified hemoglobin. Official Gazette of the United States Patent & Trademark Office Patents 1235(1), June 6

Compounds for producing 2-naphthamide derivative. Official Gazette of the United States Patent & Trademark Office Patents 1234(2), May 9

Compounds for protecting hydroxyls and methods for their use. Official Gazette of the United States Patent & Trademark Office Patents 1251(5), Oct 30

Compounds for reducing ischemia/reperfusion injury. Official Gazette of the United States Patent & Trademark Office Patents 1223(3), Jun 15

Compounds for reversing drug resistance. Official Gazette of the United States Patent & Trademark Office Patents 1251(1), Oct 2

Compounds for stimulating nerve growth. Official Gazette of the United States Patent & Trademark Office Patents 1238(1), Sep 5

Compounds for targeting. Official Gazette of the United States Patent & Trademark Office Patents 1227(4), Oct 26

Compounds for targeting and imaging infection and inflammation. Official Gazette of the United States Patent & Trademark Office Patents 1265(2), Dec 10

Compounds for the Synthesis of Nucleotide or oligonucleotide phosphoramidites. Official Gazette of the United States Patent & Trademark Office Patents 1261(4), Aug 27

Compounds for the diagnosis of Chlamydial infection. Official Gazette of the United States Patent & Trademark Office Patents 1262(2), Sep 10

Compounds for the inhibition of farnesyl protein transferase. Official Gazette of the United States Patent & Trademark Office Patents 1271(2), June 10

Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof. Official Gazette of the United States Patent & Trademark Office Patents 1263(2), Oct 8

Compounds for the modulation of PPARgamma activity. Official Gazette of the United States Patent & Trademark Office Patents 1285(1), Aug 3

Compounds for the photodecontamination of pathogens in blood. Official Gazette of the United States Patent & Trademark Office Patents 1263(4), Oct 22

Compounds for the treatment of alzheimers disease. Official Gazette of the United States Patent & Trademark Office Patents 1270(4), May 27

Compounds for the treatment of cancer. Official Gazette of the United States Patent & Trademark Office Patents 1244(1), Mar 6

Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same. Official Gazette of the United States Patent & Trademark Office Patents 1247(3), June 19

Compounds for the treatment of estrogen-dependent illnesses and methods of making and using the same. Official Gazette of the United States Patent & Trademark Office Patents 1261(2), Aug 13

Compounds for the treatment of female sexual dysfunction. Official Gazette of the United States Patent & Trademark Office Patents 1282(2), May 11

Compounds for the treatment of ischemia. Official Gazette of the United States Patent & Trademark Office Patents 1287(2), Oct 12

Compounds for the treatment of obesity. Official Gazette of the United States Patent & Trademark Office Patents 1256(2), Mar 12

Compounds for therapy and diagnosis of lung cancer and methods for their use. Official Gazette of the United States Patent & Trademark Office Patents 1262(1), Sep 3

Compounds for treating and preventing diabetic complications. Official Gazette of the United States Patent & Trademark Office Patents 1250(4), Sep 25

Compounds for treating fibromyalgia and chronic fatigue syndrome. Official Gazette of the United States Patent & Trademark Office Patents 1269(5), Apr 29

Compounds for treating fungal pathologies of the oral cavity. Official Gazette of the United States Patent & Trademark Office Patents 1285(4), Aug 24

Compounds for treating gastroduodenal diseases. Official Gazette of the United States Patent & Trademark Office Patents 1257(3), Apr 16

Compounds for treating skin conditions. Official Gazette of the United States Patent & Trademark Office Patents 1253(4), Dec 25

Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use. Official Gazette of the United States Patent & Trademark Office Patents 1280(4), Mar 23

Compounds for treatment of infectious and immune system disorders and methods for their use. Official Gazette of the United States Patent & Trademark Office Patents 1256(3), Mar 19

Compounds for use as antidepressants, aphrodisiacs and adjunctive therapies in humans. Official Gazette of the United States Patent & Trademark Office Patents 1277(4), Dec 23

Compounds for use in 11-oxa prostaglandin synthesis. Official Gazette of the United States Patent & Trademark Office Patents 1274(3), Sep 16

Compounds for use in the treatment of cancer or viral infections. Official Gazette of the United States Patent & Trademark Office Patents 1281(2), Apr 13

Compounds formed from two or three antibiotics and their processes of preparation. Official Gazette of the United States Patent & Trademark Office Patents 1261(3), Aug 20

Compounds from moraxella catarrhalis. Official Gazette of the United States Patent & Trademark Office Patents 1274(5), Sep 30

Compounds having MIF antagonist activity. Official Gazette of the United States Patent & Trademark Office Patents 1265(2), Dec 10

Compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof. Official Gazette of the United States Patent & Trademark Office Patents 1227(3), Oct 19

Compounds having activity as inhibitors of cytochrome P450RAI. Official Gazette of the United States Patent & Trademark Office Patents 1280(5), Mar 30

Compounds having affinity for the granulocyte-colony stimulating factor receptor and associated uses. Official Gazette of the United States Patent & Trademark Office Patents 1281(1), Apr 6

Compounds having anticancer activity process for their preparation and pharmaceutical compositions containing them. Official Gazette of the United States Patent & Trademark Office Patents 1271(2), June 10

Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them. Official Gazette of the United States Patent & Trademark Office Patents 1224(3), Jul 20

Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties. Official Gazette of the United States Patent & Trademark Office Patents 1270(1), May 6

Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties. Official Gazette of the United States Patent & Trademark Office Patents 1257(4), Apr 23

Compounds having antiinflamatory activity process for their preparation and pharmaceutical compositions containing them. Official Gazette of the United States Patent & Trademark Office Patents 1279(1), Feb 3

Compounds having antitumor activity process for their preparation and pharmaceutical compositions containing them. Official Gazette of the United States Patent & Trademark Office Patents 1259(4), June 25

Compounds having antiviral activity. Official Gazette of the United States Patent & Trademark Office Patents 1269(1), Apr 1

Compounds having bicyclo skeleton. Official Gazette of the United States Patent & Trademark Office Patents 1246(1), May 1

Compounds having cGMP-PDE inhibitory effect. Official Gazette of the United States Patent & Trademark Office Patents 1264(1), Nov 5

Compounds having cytokine inhibitory activity. Official Gazette of the United States Patent & Trademark Office Patents 1265(2), Dec 10

Compounds having effects on serotonin-related systems. Official Gazette of the United States Patent & Trademark Office Patents 1242(2), Jan 9

Compounds having energy transfer function and method for DNA base sequencing by using the same. Official Gazette of the United States Patent & Trademark Office Patents 1264(3), Nov 19

Compounds having fungicidal activity and processes to make and use same. Official Gazette of the United States Patent & Trademark Office Patents 1288(2), Nov 9

Compounds having growth hormone releasing activity. Official Gazette of the United States Patent & Trademark Office Patents 1263(4), Oct 22

Compounds having lectinic properties and their biological applications. Official Gazette of the United States Patent & Trademark Office Patents 1285(2), Aug 10

Compounds having protected hydroxy groups. Official Gazette of the United States Patent & Trademark Office Patents 1261(3), Aug 20

Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase. Official Gazette of the United States Patent & Trademark Office Patents 1262(1), Sep 3

Compounds having selective hydrolytic potentials. Official Gazette of the United States Patent & Trademark Office Patents 1285(4), Aug 24

Compounds in bleaching filtrates interfering with the action of oxalate-degrading enzymes. Abstracts of Papers American Chemical Society 223(1-2): CELL 41

Compounds in metathoracic glands of adults of the Sunn Pest, Eurygaster integriceps. Munis Entomology & Zoology: 1, 232-239

Compounds inhibiting the association of the PDGF receptor and phosphatidylinositol 3-kinase and their use. Official Gazette of the United States Patent & Trademark Office Patents 1239(4), Oct 24

Compounds interaction on the biodegradation of acetone and methyl ethyl ketone mixture in a composite bead biofilter. Bioresource Technology 101(1): 126-130

Compounds isolated from M vaccae and their use in modulation of immune responses. Official Gazette of the United States Patent & Trademark Office Patents 1256(4), Mar 26

Compounds obtained from salvia species having antiviral Activity. Official Gazette of the United States Patent & Trademark Office Patents 1232(2), Mar 14

Compounds of azetidine and pyrrolidin. Official Gazette of the United States Patent & Trademark Office Patents 1259(2), June 11

Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses. Official Gazette of the United States Patent & Trademark Office Patents 1282(1), May 4

Compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses. Official Gazette of the United States Patent & Trademark Office Patents 1254(1), Jan 1

Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetic and pharmaceuticals. Official Gazette of the United States Patent & Trademark Office Patents 1234(1), May 2

Compounds of the benzylaminodiacetamide family, compositions comprising them, preparation process and uses. Official Gazette of the United States Patent & Trademark Office Patents 1250(3), Sep 18

Compounds of the indolecarboxylic family and use thereof. Official Gazette of the United States Patent & Trademark Office Patents 1272(4), July 22

Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof. Official Gazette of the United States Patent & Trademark Office Patents 1279(1), Feb 3

Compounds on the pathway to quinolines. Abstracts of Papers American Chemical Society 226(1-2): ORGN 394

Compounds possessing neuronal activity. Official Gazette of the United States Patent & Trademark Office Patents 1248(5), July 31

Compounds related to natural sources and their use as biopesticides. Official Gazette of the United States Patent & Trademark Office Patents 1269(2), Apr 8

Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof. Official Gazette of the United States Patent & Trademark Office Patents 1240(1), Nov 7

Compounds related to the selective iNOS inhibitor N6- -L-lysine. Nitric Oxide 6(4): 449-450, June

Compounds selection and prioritization during lead identification Which compounds to screen and in what order?. Abstracts of Papers American Chemical Society 223(1-2): COMP 137

Compounds selectively inhibiting gamma 9 delta 2 T lymphocytes. Official Gazette of the United States Patent & Trademark Office Patents 1274(4), Sep 23

Compounds specific for the human alpha1d adrenergic receptor and uses thereof. Official Gazette of the United States Patent & Trademark Office Patents 1280(3), Mar 16

Compounds that bind bacterial pili. Official Gazette of the United States Patent & Trademark Office Patents 1229(1), Dec 7

Compounds that bind growth to hormone receptor. Official Gazette of the United States Patent & Trademark Office Patents 1258(2), May 14

Compounds that block both intermediate-conductance and small-conductance calcium-activated potassium channels. British Journal of Pharmacology 129(7): 1431-1438, April

Compounds that effect the polymerization of sickle cell hemoglobin in vitro. Biophysical Journal 78(1 Part 2): 335A, Jan

Compounds that inhibit GRB2-SHC binding and process for preparing same. Official Gazette of the United States Patent & Trademark Office Patents 1274(3), Sep 16

Compounds that inhibit T cell proliferation and methods using the same. Official Gazette of the United States Patent & Trademark Office Patents 1226(4), Sep 28

Compounds that inhibit factor Xa activity. Official Gazette of the United States Patent & Trademark Office Patents 1286(3), Sep 21

Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using. Official Gazette of the United States Patent & Trademark Office Patents 1266(2), Jan 14

Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same. Official Gazette of the United States Patent & Trademark Office Patents 1276(1), Nov 4

Compounds that inhibit the binding of RAF-1 or 14-3-3 proteins to the beta chain of IL-2 receptor, and pharmaceutical compositions containing same. Official Gazette of the United States Patent & Trademark Office Patents 1249(4), Aug 28

Compounds that inhibit the binding of integrins to their receptors. Official Gazette of the United States Patent & Trademark Office Patents 1237(1), Aug 1

Compounds that modulate multidrug resistance in cancer cells. Cellular & Molecular Biology Letters 6(2A): 362-368

Compounds that modulate the activity of PTP-1B and TC-PTP. Official Gazette of the United States Patent & Trademark Office Patents 1285(5), Aug 31

Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof. Official Gazette of the United States Patent & Trademark Office Patents 1275(2), Oct 14

Compounds to treat Alzheimers disease. Official Gazette of the United States Patent & Trademark Office Patents 1282(3), May 18

Compounds to treat diabetes and associated conditions. Official Gazette of the United States Patent & Trademark Office Patents 1267(4), Feb 25

Compounds useful as anti-inflammatory agents. Official Gazette of the United States Patent & Trademark Office Patents 1256(3), Mar 19

Compounds useful as antibacterial agents. Official Gazette of the United States Patent & Trademark Office Patents 1278(1), Jan 6

Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same. Official Gazette of the United States Patent & Trademark Office Patents 1280(5), Mar 30

Compounds useful as neuro-protective agents. Official Gazette of the United States Patent & Trademark Office Patents 1241(1), Dec 5

Compounds useful as phosphotyrosine mimics. Official Gazette of the United States Patent & Trademark Office Patents 1241(1), Dec 5

Compounds useful as reversible inhibitors of cathepsin S. Official Gazette of the United States Patent & Trademark Office Patents 1273(3), Aug 19

Compounds useful as reversible inhibitors of cathespin S. Official Gazette of the United States Patent & Trademark Office Patents 1282(1), May 4

Compounds useful as reversible inhibitors of cysteine proteases. Official Gazette of the United States Patent & Trademark Office Patents 1267(4), Feb 25

Compounds useful for inhibition of farnesyl protein transferase. Official Gazette of the United States Patent & Trademark Office Patents 1259(4), June 25

Compounds useful for inhibition of farnesyl protein transferase. Official Gazette of the United States Patent & Trademark Office Patents 1279(2), Feb 10

Compounds useful for inhibition of farnesyl proteins transferase. Official Gazette of the United States Patent & Trademark Office Patents 1218(3): 2213-2214, Jan 19

Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds. Official Gazette of the United States Patent & Trademark Office Patents 1258(2), May 14

Compounds useful for the synthesis of dolastatin analogs. Official Gazette of the United States Patent & Trademark Office Patents 1220(4): 3605-3606, March 23

Compounds useful for treating hepatitis C virus. Official Gazette of the United States Patent & Trademark Office Patents 1287(2), Oct 12

Compounds useful for treatment of cancer, compositions containing the same, and methods of their use. Official Gazette of the United States Patent & Trademark Office Patents 1284(2), July 13

Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor. Official Gazette of the United States Patent & Trademark Office Patents 1284(4), July 27

Compounds useful in pain management. Official Gazette of the United States Patent & Trademark Office Patents 1265(4), Dec 24

Compounds useful in preparing camptothecin derivatives. Official Gazette of the United States Patent & Trademark Office Patents 1281(3), Apr 20

Compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation. Official Gazette of the United States Patent & Trademark Office Patents 1276(4), Nov 25

Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors. Official Gazette of the United States Patent & Trademark Office Patents 1247(3), June 19

Compounds useful in the treatment of neurofibromatosis. Official Gazette of the United States Patent & Trademark Office Patents 1241(2), Dec 12

Compounds useful in therapy. Official Gazette of the United States Patent & Trademark Office Patents 1288(1), Nov 2

Compounds which affect mRNA stability and uses therefor. Official Gazette of the United States Patent & Trademark Office Patents 1275(3), Oct 21

Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools. Official Gazette of the United States Patent & Trademark Office Patents 1238(4), Sep 26

Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications. Official Gazette of the United States Patent & Trademark Office Patents 1246(1), May 1

Compounds which inhibit leukocyte adhesion mediated by VLA-4. Official Gazette of the United States Patent & Trademark Office Patents 1261(3), Aug 20

Compounds which inhibit tryptase activity. Official Gazette of the United States Patent & Trademark Office Patents 1256(4), Mar 26

Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease. Official Gazette of the United States Patent & Trademark Office Patents 1255(3), Feb 19

Compounds which maintain the NAD+/NADH ratio attenuated neuronal death induced by MPP+, 6 - hydroxydopamine, and 3 - nitroproprionic acid in vitro and in vivo. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 535 4

Compounds which modify serotoninergic transmission, diagnostic and therapeutic applications. Official Gazette of the United States Patent & Trademark Office Patents 1280(5), Mar 30

Compounds which prevent neuronal cell death and uses thereof. Official Gazette of the United States Patent & Trademark Office Patents 1275(3), Oct 21

Compounds with a sulfamate group. Official Gazette of the United States Patent & Trademark Office Patents 1236(1), July 4

Compounds with activity on muscarinic receptors. Official Gazette of the United States Patent & Trademark Office Patents 1268(1), Mar 4

Compounds with an antioxidant activity, compositions useful as food integrators containing them and process for their preparation. Official Gazette of the United States Patent & Trademark Office Patents 1269(2), Apr 8

Compounds with analgesic effect. Official Gazette of the United States Patent & Trademark Office Patents 1239(2), Oct 10

Compounds with anti-KS and anti-HIV activity. Official Gazette of the United States Patent & Trademark Office Patents 1278(4), Jan 27

Compounds with anti-inflammatory and immunosuppressive activities. Official Gazette of the United States Patent & Trademark Office Patents 1232(1), Mar 7

Compounds with antitumor activity. Official Gazette of the United States Patent & Trademark Office Patents 1269(2), Apr 8

Compounds with biologically active silicon and applications. Official Gazette of the United States Patent & Trademark Office Patents 1245(1), Apr 3

Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury. Official Gazette of the United States Patent & Trademark Office Patents 1248(4), July 24

Compounds with chelation affinity and selectivity for first transition series elements Use in medical therapy. Official Gazette of the United States Patent & Trademark Office Patents 1219(4): 3400-3401, Feb 23

Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury. Official Gazette of the United States Patent & Trademark Office Patents 1258(2), May 14

Compounds with chelation affinity and selectivity for first transition series elements use in medical therapy and diagnosis. Official Gazette of the United States Patent & Trademark Office Patents 1263(4), Oct 22

Compounds with chelation affinity selectivity for first transition series elements use in medical therapy and diagnosis. Official Gazette of the United States Patent & Trademark Office Patents 1241(4), Dec 26

Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use. Official Gazette of the United States Patent & Trademark Office Patents 1244(4), Mar 27

Compounds with growth hormone releasing properties. Official Gazette of the United States Patent & Trademark Office Patents 1249(2), Aug 14

Compounds with growth hormone releasing properties. Official Gazette of the United States Patent & Trademark Office Patents 1255(4), Feb 26

Compounds with growth hormone releasing properties. Official Gazette of the United States Patent & Trademark Office Patents 1269(5), Apr 29

Compounds with high monoamine transporter affinity. Official Gazette of the United States Patent & Trademark Office Patents 1267(4), Feb 25

Compounds with hydroxycarbonyl-halogenoalkyl side chain. Official Gazette of the United States Patent & Trademark Office Patents 1282(3), May 18

Compounds with pharmaceutical properties. Official Gazette of the United States Patent & Trademark Office Patents 1242(2), Jan 9

Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception. Official Gazette of the United States Patent & Trademark Office Patents 1256(4), Mar 26

Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes. Official Gazette of the United States Patent & Trademark Office Patents 1275(3), Oct 21

Compounds, compositions and methods for generating chemiluminescene with phosphatase enzymes. Official Gazette of the United States Patent & Trademark Office Patents 1245(3), Apr 17

Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins. Official Gazette of the United States Patent & Trademark Office Patents 1224(2), Jul 13

Compounds, compositions and methods for preventing and treating pestivirus infection and associated diseases. Official Gazette of the United States Patent & Trademark Office Patents 1269(1), Apr 1

Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system. Official Gazette of the United States Patent & Trademark Office Patents 1271(1), June 3

Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors. Official Gazette of the United States Patent & Trademark Office Patents 1282(3), May 18

Compounds, compositions and methods for treating influenza. Official Gazette of the United States Patent & Trademark Office Patents 1242(5), Jan 30

Compounds, compositions and methods for treatment of hepatitis C. Official Gazette of the United States Patent & Trademark Office Patents 1239(1), Oct 3

Compounds, compositions, and methods for cancer imaging and therapy. Official Gazette of the United States Patent & Trademark Office Patents 1224(1), Jul 6

Compounds, compositions, and methods for stimulating neuronal growth and elongation. Official Gazette of the United States Patent & Trademark Office Patents 1269(2), Apr 8

Compounds, compositions, and methods for treating erectile dysfunction. Official Gazette of the United States Patent & Trademark Office Patents 1238(4), Sep 26

Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage. Official Gazette of the United States Patent & Trademark Office Patents 1281(1), Apr 6

Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage. Official Gazette of the United States Patent & Trademark Office Patents 1251(4), Oct 23

Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products. Official Gazette of the United States Patent & Trademark Office Patents 1273(2), Aug 12

Compounds, pharmaceutical compositions, and methods for inhibiting protein kinases. Official Gazette of the United States Patent & Trademark Office Patents 1263(2), Oct 8

Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation. Official Gazette of the United States Patent & Trademark Office Patents 1275(1), Oct 7

Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds. Official Gazette of the United States Patent & Trademark Office Patents 1244(4), Mar 27

Compounds, their preparation and use. Official Gazette of the United States Patent & Trademark Office Patents 1278(4), Jan 27

Comprative Pharmacodynamics and Pharmacokinetics of RO-14 and Heparin Pentasaccharide in Primates. Blood 100(11): Abstract No 4013, November 16

Comprehending ambiguous sentences in Parkinsons Disease. Neurology 58(7 Supplement 3): A354-A355, April 9

Comprehending complexity together with the public Practical strategies for improving rangeland conservation, restoration and management. Ecological Society of America Annual Meeting Abstracts 87: 25

Comprehending endocrine disrupters in aquatic environments Additional projects arose from a three-year, multinational, multidisciplinary research program in the European Union. Environmental Science & Technology 37(17): 331A-336A, September 1

Comprehension and hazard communication of three pictorial symbols designed for flight manual warnings. Safety Science: 4, 478-481

Comprehension of motor control and Bernstein problem by memory compression and similarity to formation of visual knowledge structure. Neuroscience Research Supplement (24): S155

Comprehension of scientific data Integrating proper instrucmentatation and scientific annalysis. AAAS Annual Meeting & Science Innovation Exposition 166: A91, February 17-22

Comprehension of time-reversed speech As indicator for the level of language proficiency. Society for Neuroscience Abstracts 26(1-2): Abstract No -464 26

Comprehension skill predicts N400 in locally, globally, and noncongruent sentence processing. Psychophysiology 37(Supplement 1): S65, August

Comprehensive 2D capillary LC as front end separation technique in MS proteomics. Molecular & Cellular Proteomics 1(9): 697, September

Comprehensive 2D gas chromatography More than just nice pictures. Journal of Separation Science 25(7): 391, May

Comprehensive DNA analysis using pyrosequencing technology. American Journal of Medical Genetics 114(7): 702, October 8

Comprehensive DNA methylation study in 40 uveal melanomas. American Journal of Human Genetics 69(4 Supplement): 267, October

Comprehensive Doppler echocardiography and B-type natriuretic peptide in the diagnosis of elevated left ventricular filling pressures in patients with pulmonary artery catheters. Circulation 108(17 Supplement): IV-393-IV-394, October 28

Comprehensive Gene Expression Analysis of Human Neurosensory Retina. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 3656

Comprehensive HCV genome-wide analysis of CD4+ and CD8+ T cells reveals hierarchy of immunodominance. Hepatology 38(4 Suppl 1): 344A, October

Comprehensive Multiparametric Immunophenotyping of Plasma Cell Neoplasia by Flow Cytometry. Blood 100(11): Abstract No 5076, November 16

Comprehensive NMR studies on Eucalyptus globulus lignins. Abstracts of Papers American Chemical Society 223(1-2): CELL 50

Comprehensive Phenotyping for Rheumatoid Arthritis. FASEB Journal 18(4-5): Abst 778 19

Comprehensive allelotype study of hepatocellular carcinoma. Hepatology 32(4 Pt 1): 876-876

Comprehensive allelotype study of ovarian tumor of low malignant potential Potential differences in pathways between tumors with and without genetic predisposition to invasive carcinoma. International Journal of Cancer Supplement (13): 390

Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma using high throughput automated DNA sequencer. Hepatology 32(4 Pt 2): 236A, October

Comprehensive alleotype study of hepatocellular carcinoma revealed allelic losses on specific chromosomes are correlated with HBV infection. Hepatology 30(4 PART 2): 272A, Oct

Comprehensive analyses and characterization of haemophagocytic lymphohistiocytosis in Vietnamese children. British Journal of Haematology 148(2): 301-310

Comprehensive analysis of DNA hypermethylation and mismatch repair genes in primary gastric adenocarcinoma. Gastroenterology 123(1 Supplement): 21, July

Comprehensive analysis of cDNAs involved in development of Dictyostelium discoideum. Development Growth & Differentiation 43(Supplement): S7, July

Comprehensive analysis of candidate modifier genes for multiple sclerosis on chromosome 19q13. American Journal of Human Genetics 73(5): 368, November

Comprehensive analysis of clinical and molecular determinants of second events in the randomized Retinoid Head and Neck Second Primary Tumor Prevention Trial. Proceedings of the American Association for Cancer Research Annual Meeting 43: 514-515, March

Comprehensive analysis of complex proteomes using Zoom IEF prefractionation and high throughput narrow range 2-D gels. Molecular & Cellular Proteomics 2(9): 815, September

Comprehensive analysis of conserved non-genic sequences on human chromosome 21. American Journal of Human Genetics 73(5): 433, November

Comprehensive analysis of death and nonfatal myocardial infarction during the first twelve months following acute non Q-wave myocardial infarction Comparison of invasive versus conservative strategies in the VA Non Q-Wave Infarction Strategies In-Hospital Trial. Journal of the American College of Cardiology 37(2 Supplement A): 336A, February

Comprehensive analysis of gene expression in human prostate. Proceedings of the American Association for Cancer Research Annual Meeting (41): 683, March

Comprehensive analysis of gene expression in intracranial aneurysm. American Journal of Human Genetics 65(4): A274, Oct

Comprehensive analysis of genes expressed in Drosophila gonads. Zoological Science (Tokyo) 19(12): 1451, December

Comprehensive analysis of mRNA expression profiles in human respiratory epithelial cells after inoculation with Respiratory Syncytial Virus. Journal of Allergy & Clinical Immunology 113(2 Supplement): S267, February

Comprehensive analysis of mismatch repair proficiency in leukemia cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1026, March

Comprehensive analysis of molecular genetic polymorphisms associated with isoniazid resistance in human isolates of Mycobacterium tuberculosis. Abstracts of the General Meeting of the American Society for Microbiology 99: 635

Comprehensive analysis of prognostic implications of cytogenetic abnormalities in multiple myeloma in the tandem autotransplant setting. Blood 96(11 Part 1): 548a, November 16

Comprehensive analysis of promoter methylation and altered expression of hMLH1 gene in gastric cancer cell lines with microsatellite instability. Proceedings of the American Association for Cancer Research Annual Meeting 42: 905, March

Comprehensive analysis of protein levels of drug resistant and sensitive yeast strains. Environmental & Molecular Mutagenesis 37(Supplement 32): 57

Comprehensive analysis of protein networks and disease pathways. Biophysical Journal 84(2 Part 2): 2a, February

Comprehensive analysis of the HCV-specific CD8+ T cell response in individuals with chronic or resolved HCV infection. Hepatology 34(4 Pt 2): 432A, October

Comprehensive analysis of the factor H binding capability of the Lyme disease isolates. Abstracts of the General Meeting of the American Society for Microbiology 103: D-162

Comprehensive analysis of the frequency of recognition of melanoma-associated antigen by CD8 melanoma infiltrating lymphocytes Implications for immunotherapy. European Journal of Immunology 31(7): 2007-2015, July

Comprehensive analysis of the genes required for the expression of a type-IV fimbria and localized adherence in enteropathogenic Escherichia coli. Abstracts of the General Meeting of the American Society for Microbiology 99: 40

Comprehensive analysis of two-component signal transduction system induced multidrug resistance in Escherichia coli. Abstracts of the General Meeting of the American Society for Microbiology 103: H-125

Comprehensive analysis of uncharacterized human cDNAs that encode large proteins in brain. Neuroscience Research Supplement (26): S6, 2002( )

Comprehensive and comparative in vitro analysis of the effects of lamivudine and clevudine on HBV DNA species. Hepatology 36(4 Part 2): 645A, October

Comprehensive and detailed analysis of pulmonary veins, left atrial appendage, and their interrelations with gadolinium enhanced magnetic resonance angiography and 3-D navigation view analysis. Journal of the American College of Cardiology 39(5 Supplement A): 113A-114A, March 6

Comprehensive and quantitative proteomic analyses of plasma membrane proteins from human cells. Molecular & Cellular Proteomics 2(7 Supplement): S78, July

Comprehensive and systematic analysis of function and expression of all the 51 missense mutants of sarco plasmic reticulum Ca2+-ATPase 2b found in Dariers disease patients. Journal of Investigative Dermatology 121(1): 0655, July

Comprehensive and systematic analysis of function and expression of the 51 missense mutants of SERCA2B found in Dariers disease patients. Journal of Dermatological Science 34(2): 131, April

Comprehensive anthropological studies and facial reconstruction concerning skulls of 14 persons killed during world war II. Forensic Science International 136(Suppl 1): 173, September

Comprehensive appraisal of new flue-cured tobacco varieties with grey situation decision making. Journal Of China Agricultural University: 1, 95-98

Comprehensive approach for the identification of inducible genes coupled to activation of muscarinic acetylcholine receptors. Society for Neuroscience Abstracts 25(1-2): 1723

Comprehensive approach to preventing surgical-site infections. Infection Control & Hospital Epidemiology 24(12), December

Comprehensive approaches to improving health and social status of under-served young urban Black men. Ethnicity & Disease 12(Supplement 3): S3 139

Comprehensive assay development for hereditary non-polyposis colon cancer. American Journal of Human Genetics 71(4 Supplement): 249, October

Comprehensive assessment for dementia: a necessity for differential diagnosis and management. Seminars in Speech and Language 22(4): 275-88; Quiz 289

Comprehensive assessment of QT dispersion in various at risk groups including acute myocardial infarction, unstable angina, hypertrophic cardiomyopathy, idiopathic dilated cardiomyopathy, and healthy controls. European Heart Journal 20(ABSTR SUPPL ): 591, Aug

Comprehensive assessment of coronary artery disease with magnetic resonance imaging. Journal of the American College of Cardiology 39(5 Supplement A): 347A, March 6

Comprehensive assessment of school boys physical development in an industrial town. Gigiena i Sanitariya (1): 74-76, Jan -Feb

Comprehensive assessment of toxic metals in urban and suburban street deposited sediments in the biggest metropolitan area of China. Environmental Pollution8: 3, 694-703

Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency The Italian multicentre survey. Journal of the American Society of Nephrology 14(Abstracts Issue): 761A, November

Comprehensive banking and transplantation of sibling donor cord blood. Blood 98(11 Part 2): 361b, November 16

Comprehensive biochemical fractionation of the Tetrahymena cytoskeleton. Molecular Biology of the Cell 13(Supplement): 332a, Nov

Comprehensive biological and chemical model for in situ biodegradation of BTEX The CBC-model. Abstracts of Papers American Chemical Society 220(Part 1): ENVR 270

Comprehensive blood flow assessment in nonexudative age-related macular degeneration. IOVS 40(4): S560, March 15

Comprehensive cancer control A new approach. International Journal of Cancer Supplement (13): 157

Comprehensive cardiac rehabilitation for implantable cardiac defibrillator patients A randomised controlled trial. European Heart Journal 22(Abstract Supplement): 140, September

Comprehensive cardiovascular manifestations of carbon monoxide poisoning. JGIM 14(SUPPL 2): 168, April

Comprehensive characterization of 40 inbred mouse strains reveals broad diversity in cardiovascular phenotypes. Circulation 106(19 Supplement): II-207, November 5

Comprehensive characterization of cell lines and laryngeal carcinomas containing genomic amplifications in the chromosome 11q13 region by use of high density array CGH. Analytical Cellular Pathology 25(5-6): 285

Comprehensive characterization of genetic diversity among Helicobacter pylori isolates obtained years apart from a single human host. IJMM International Journal of Medical Microbiology 291(Supplement 31): 117, September

Comprehensive characterization of hearing loss in aged diabetics. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 388 13

Comprehensive comparison of health-related quality of life after radical prostatectomy, high- dose intensity modulated radiotherapy and intraoperative conformal brachytherapy for localized prostate cancer. International Journal of Radiation Oncology Biology Physics 54(2 Supplement): 252

Comprehensive concept to support right ventricular function following left ventricular assist device implantation. Journal of Heart & Lung Transplantation 18(1): 89, Jan

Comprehensive conservation planning and ecosystem restoration on national wildlife refuges. Ecological Society of America Annual Meeting Abstracts 87: 259

Comprehensive continuous sanitary education and training of the population under present-day conditions. Gigiena i Sanitariya (4): 67-69, July-August

Comprehensive correlation of conventional cytogenetics , FISH and quantitative real-time reverse transcriptase PCR results for detecting t in chronic myeloid leukemia patients. Modern Pathology 16(1): 257A, January

Comprehensive cost comparision of pediatric living donor liver transplantation with cadaver donor liver transplantation. Hepatology 36(4 Part 2): 192A, October

Comprehensive cost comparison of living donor liver transplantation with cadaveric transplantation. Gastroenterology 122(4 Suppl 1): A 637, April

Comprehensive cytoarchitectonic analysis of the cortical regions surrounding the hippocampus in the b6129pf1/j hybrid mouse. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 849 14

Comprehensive cytogenetic study by spectral karyotyping on blastic natural killer cell leukemia/lymphoma. American Journal of Hematology 69(3): 234-235

Comprehensive description of Irritable Bowel Syndrome by subtypes in African-Americans versus caucasians. American Journal of Gastroenterology 98(9 Supplement): S267, September

Comprehensive detection and identification of seven animal coronaviruses and human respiratory coronavirus 229E with a microarray hybridization assay. Intervirology 53(2): 95-104

Comprehensive detection of CFTR mutations in idiopathic chronic pancreatitis. American Journal of Human Genetics 71(4 Supplement): 483, October

Comprehensive determinant mapping by ELISPOT assay is capable of fully defining the HCV specific CD8 T cell repertoire in humans with self limited HCV related disease. Hepatology 32(4 Pt 2): 303A, October

Comprehensive determinant mapping of the hepatitis C specific CD8 cell repertoire reveals immune dominance among HLA-binding-motif-predicted determinants. FASEB Journal 15(4): A307, March 7

Comprehensive diabetes management A clinical pharmacy practitioner as a means to improve the health care report card. Pharmacotherapy 23(10): 1372, October

Comprehensive empirical dataset for correlating small-molecule structure with kinase inhibition. Abstracts of Papers American Chemical Society 226(1-2): MEDI 29

Comprehensive epilepsy care The undervalued benefit of nurse access and telephone follow-up. Epilepsia 44(Supplement 9): 285

Comprehensive essential gene identification as a platform for novel anti-infective drug discovery. Current Pharmaceutical Design 8(13): 1155-1172

Comprehensive evaluation and treatment of the shoulder in the throwing athlete. Arthroscopy 18(9 Suppl 2): 70-89

Comprehensive evaluation of HER-2/neu gene status in breast cancer by FISH and immunohistochemistry methodologies. American Journal of Human Genetics 65(4): A118, Oct

Comprehensive evaluation of antioxidant activity for various substances with 5-axe cobweb chart. Food Chemistry0: 1, 150-155

Comprehensive evaluation of endogenous intoxication in terms of toxicouria in hygienic studies. Gigiena i Sanitariia: 73-75

Comprehensive evaluation of the extraocular muscle critical period using serial analysis of gene expression in dark reared rats. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 4809

Comprehensive evaluation on compensatory effects of water recovery after drought based on projection pursuit classification model. Nongye Jixie Xuebao = Transactions Of The Chinese Society For Agricultural Machinery: 1, 59-62, 33

Comprehensive examination of lung tissues from SIV-infected rhesus macaques reveals only rare productively infected cells during acute infection. Journal of Medical Primatology 30(4): 235, August

Comprehensive expressed sequence tags analysis during retinal regeneration process. IOVS 42(4): S752, March 15

Comprehensive expression analysis of genetic responses in yeast cells to low temperature using microarray. Yeast 20(Supplement 1): S200, July

Comprehensive expression analysis suggests overlapping and specific roles of rice glutathione S-transferase genes during development and stress responses. Bmc Genomics 11: 73-73

Comprehensive expression profile of a newly cloned RNA binding protein gene. American Journal of Human Genetics 71(4 Supplement): 331, October

Comprehensive fetal ultrasound growth measurements in triplet gestations. American Journal of Obstetrics & Gynecology 180(1 PART 2): S159, Jan

Comprehensive field observations of sea salt chemistry over Houston/Galveston area. Abstracts of Papers American Chemical Society 224(1-2): PHYS 229

Comprehensive fluorescence in situ hybridization analysis on pathological stage T3N0M0 prostate carcinoma. Journal of Urology 163(4 Suppl ): 103, April

Comprehensive gene expression analyses by EST during retinal regeneration. Development Growth & Differentiation 43(Supplement): S50, July

Comprehensive gene expression analysis in focal cerebral ischemia. Society for Neuroscience Abstracts 27(1): 538

Comprehensive gene expression analysis of Arabidopsis 5th chromosome long arm region by genome DNA array. Plant & Cell Physiology 42(Supplement): s198

Comprehensive gene expression analysis of metastatic prostate cancer reveals distinct transcriptional programs and potential prognostic markers. Laboratory Investigation 82(1): 169A, January

Comprehensive gene expression analysis of paired primary breast carcinomas and lymph node metastases. Proceedings of the American Association for Cancer Research Annual Meeting 44: 36-37, July

Comprehensive gene expression analysis predicts postoperative prognosis of ER-negative breast cancer. Breast Cancer Research & Treatment 76(Supplement 1): S81, December

Comprehensive gene expression analysis predicts postoperative prognosis of lymph node negative breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1203, July

Comprehensive gene expression analysis using oligonucleotide microarrays aimed at identification of candidate genes for determination of susceptibility to colon carcinogenesis induced by PhIP. Cancer Epidemiology Biomarkers & Prevention 11(10 Part 2): 1156s, October

Comprehensive gene expression profile of hepatocellular carcinoma complicated in viral hepatitis. Hepatology 34(4 Pt 2): 265A, October

Comprehensive gene expression profile of the acute methamphetamine treated rat cortex by the serial analysis of gene expression. Journal of Neurochemistry 78(Supplement 1): 165, September

Comprehensive gene expression profile of the adult human renal cortex Analysis by cDNA array hybridization and comparison with murine orthologous genes. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 592A, Sept

Comprehensive gene expression profile of the matrix metalloproteinase gene family in normal human tissue and major cancers. American Journal of Human Genetics 69(4 Supplement): 243, October

Comprehensive gene expression profiles of adrenal cortical tumors. Laboratory Investigation 82(1): 115A, January

Comprehensive gene expression profiles of cytokines in patients with minimal change nephrotic syndrome analyzed by cDNA array. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 97A, September

Comprehensive gene expression profiles of papillary thyroid carcinoma. Laboratory Investigation 82(1): 115A, January

Comprehensive gene expression profiling analysis in minimal change nephrotic syndrome using cDNA array A novel approach to the mechanism of proteinurea. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 102A, September

Comprehensive gene expression profiling analysis in minimal change nephrotic syndrome using cDNA array A novel approach to the mechanism of proteinuria. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 130A, September

Comprehensive gene expression profiling analysis using cDNA arrays in rats exposed to several kinds of stress conditions. Hepatology 34(4 Pt 2): 514A, October

Comprehensive genetic analysis of nuclear receptor genes in age related maculopathy. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 1505

Comprehensive genomic DNA-chip hybridization in mantle cell lymphomas Delineation of novel consensus regions and simultaneous analysis of cell cycle regulation genes. Blood 102(11): 217a, November 16

Comprehensive genotypic analysis of leukemia: clinical and therapeutic implications. Current Opinion in Oncology 14(1): 10-18

Comprehensive geriatric assessment: a useful tool for prevention of acute situations in the elderly. Annales de Medecine Interne 153(6): 397-402

Comprehensive geriatric assessment in elderly cancer patients Impact on overall survival and progression-free survival. Journal of the American Geriatrics Society 47(9): S30, Sept

Comprehensive geriatric assessment of older patients with gastrointestinal disorders. Pilotto, Alberto [Editor, Reprint Author], Malfertheiner, Peter [Editor], Holt, Peter R [Editor] Aging and the gastrointestinal tract : 12-27

Comprehensive health care needed for New Hampshires incarcerated youths. Pediatric Research 51(4 Part 2): 5A, April

Comprehensive health outcomes of babies known to have fetal inflammatory response syndrome at delivery. American Journal of Obstetrics & Gynecology 189(6 Supplement): S152, September

Comprehensive hepatitis empowerment program improves awareness and follow-up across ethnic groups in patients with positive HCV antibody. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A148, April

Comprehensive high-throughput mutation-screening of BRCA1 and BRCA2. Journal of Microbiological Methods 38(3): 213, Nov

Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes. Analytical Biochemistry 288(1): 106-108

Comprehensive hygienic assessment of the environment and its impact on the populations health of a region. Gigiena i Sanitariya 0(2): 47-49, March-April

Comprehensive hypercoagulable state testing is indicated in patients with a first idiopathic deep venous thrombosis. Medical Clinics of North America 87(6): 1237-1250

Comprehensive hypertension care in underserved urban black men High follow-up rates and blood pressure improvement over 60 months. Circulation 108(17 Supplement): IV-381, October 28

Comprehensive identification of NF-kB activation in SKOV-3WT cells with cisplatin treatment by gene chip hybridization. Proceedings of the American Association for Cancer Research Annual Meeting (41): 866, March

Comprehensive identification of frameshift mutations caused by coding region microsatellite instability in MSI-H gastric cancers. Proceedings of the American Association for Cancer Research Annual Meeting 43: 285, March

Comprehensive identification of projection neurons connecting optic lobes and the central brain of Drosophila. Neuroscience Research Supplement (24): S71

Comprehensive identification of radiation-response genes by high coverage expression profile analysis technology. Journal of Radiation Research 41(4): 397, December

Comprehensive infection control measures reduce nosocomial infection rates in a neonatal intensive care unit. Pediatric Research 51(4 Part 2): 301A, April

Comprehensive integration and cataloguing of chromosome 1 using CompView. Cytogenetics & Cell Genetics 87(3-4): 170

Comprehensive investigation of arsenic speciation in soils and sediments using phosphate solutions as extraction media. Abstracts of Papers American Chemical Society 223(1-2): ANYL 18

Comprehensive isolation of natural organic matter from water for spectral characterizations and reactivity testing. Abstracts of Papers American Chemical Society 217(1-2): ENVR 34

Comprehensive karyotyping of the human HT-29 colon carcinoma cell line. Proceedings of the American Association for Cancer Research Annual Meeting 42: 66, March

Comprehensive kinetic characterization of tamoxifen primary demethylation and hydroxylation by the human cytochrome P450s. Drug Metabolism Reviews 35(Supplement 2): 189

Comprehensive lactation education and support program increases patient satisfaction and the percentage of women still breastfeeding six months postpartum. Pediatric Research 53(4 Part 2): 565A, April

Comprehensive life cycle inventories of alternative wastewater treatment systems. Water Research 44(5): 1654-1666

Comprehensive longitudinal analysis of cellular immune responses and viral evolution in a person with acute HCV infection requiring antiviral treatment. Hepatology 36(4 Part 2): 543A, October

Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1. Virology 398(2): 290-298

Comprehensive mechanism-of-action based clustering of anti-cancer drugs by large-scale transcriptional profiling. Proceedings of the American Association for Cancer Research Annual Meeting 44: 190, July

Comprehensive medical and nursing management decreases hospital care of heart failure. European Heart Journal 20(ABSTR SUPPL ): 24, Aug

Comprehensive medicine Treatment of digestive diseases with Chinese herbs. Journal of the American College of Nutrition 19(5): 703, October

Comprehensive metabolomics using FTMS technology Theory and applications. Abstracts of Papers American Chemical Society 226(1-2): BIOL 13

Comprehensive molecular analyses of the APC gene of FAP patients Novel mutations and relation to phenotype. American Journal of Human Genetics 65(4): A316, Oct

Comprehensive molecular and morphological description of the genus Thymallus Relevance to systematic revision, conservation, and management. American Fisheries Society Annual Meeting 133: 48-49

Comprehensive molecular cytogenetic analysis of mantle cell lymphoma. Blood 94(10 SUPPL 1 PART 1): 517a, Nov 15

Comprehensive molecular cytogenetic characterization of the breast cancer cell line MCF7. Annales de Genetique 46(2-3): 163, September

Comprehensive molecular cytogenetic profiling of serous ovarian adenocarcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 43: 628, March

Comprehensive molecular genetic analysis in head and neck carcinomas revealing non random involvement of chromosome 22. Proceedings of the American Association for Cancer Research Annual Meeting 40: 191, March

Comprehensive morphological and functional MR assessment of early neonatal brain injury in a piglet model. Pediatric Research 53(4 Part 2): 542A, April

Comprehensive mutation analysis and genotype/phenotype correlations in a cohort of 227 tuberous sclerosis patients. American Journal of Human Genetics 67(4 Supplement 2): 371, October

Comprehensive mutation analysis of the MECP2 gene and the analysis of 54 Rett syndrome suspected patients. European Journal of Human Genetics 10(Supplement 1): 230

Comprehensive mutation scanning of ATM gene in patients with breast cancer reveals a higher frequency of missense mutations in breast cancer relative to ethnically matched controls. American Journal of Human Genetics 69(4 Supplement): 267, October

Comprehensive mutation scanning of RAR/RXR and vitamin D receptor genes in patients with schizophrenia and other psychiatric diseases. American Journal of Medical Genetics 114(7): 807, October 8

Comprehensive mutation scanning of RAR/RXR and vitamin D receptor genes in patients with schizophrenia and other psychiatric diseases Three missence mutations at highly conserved residues. American Journal of Human Genetics 71(4 Supplement): 503, October

Comprehensive mutation screen in the RGS9 gene in 558 patients with inherited retinal degenerations. IOVS 42(4): S646, March 15

Comprehensive mutational analysis of myosin binding protein C in 389 unrelated patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology 43(5 Supplement A): 165A, March 3

Comprehensive mutational analysis of the ATM gene by denaturing HPLC. American Journal of Human Genetics 67(4 Supplement 2): 100, October

Comprehensive mutational analysis of the lamin A/C gene in familial and sporadic dilated cardiomyopathies. American Journal of Human Genetics 69(4 Supplement): 605, October

Comprehensive non invasive phenotyping of psen1/app695 transgenic mice. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 191 9

Comprehensive noninvasive prediction of infarct artery patency and flow after fibrinolytic therapy. Circulation 102(18 Supplement): II 775, October 31

Comprehensive nurse managed program for diabetes in indigent Latino population improves care and outcomes of diabetes. Diabetes 48(SUPPL 1): A195

Comprehensive ocular hemodynamic assessment of normal eyes by Canon laser blood flowmeter, Heidelberg retinal flowmeter, and color Doppler imaging. IOVS 42(4): S212, March 15

Comprehensive peritoneal dialysis access management by interventional nephrologists in an Ambulatory Surgery Center. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 393A, September

Comprehensive pharmacologic therapy for treatment of obesity. Official Gazette of the United States Patent & Trademark Office Patents 1269(3), Apr 15

Comprehensive pharmacologic therapy for treatment of obesity including cysteine. Official Gazette of the United States Patent & Trademark Office Patents 1284(1), July 6

Comprehensive pharmacology and clinical efficacy of aromatase inhibitors. Drugs 58(2): 233-255

Comprehensive plan needed for better salmonella control. Poultry: Middle East & North Africa: 210, 24-26, 110

Comprehensive prevention of occupational blood exposures: lessons from other countries. Infection Control and Hospital Epidemiology 21(9): 562-563

Comprehensive primary health care, a viable strategy for the elimination of schistosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 104(1): 70-72

Comprehensive profiling of apoptosis regulators in B-CLL reveals overexpression of Bmf and Noxa and links cytostatic drug-induced Puma upregulation with IGVH status. Blood 102(11): 428a-429a, November 16

Comprehensive profiling of human plasma and serum proteomes using MicroSol-IEF prefractionation and major protein depletion. Molecular & Cellular Proteomics 2(9): 945, September

Comprehensive profiling of surface membrane proteins of cancer cells. Molecular & Cellular Proteomics 1(9): 675, September

Comprehensive profiling of the surface membrane proteome of cancer cells uncovers a substantial overlap with the exosomal compartment. Molecular & Cellular Proteomics 2(9): 804, September

Comprehensive proteome analysis by mass spectrometry. Molecular & Cellular Proteomics 2(9): 683, September

Comprehensive quality of life, health maintenance and symptom survey in dialysis patients. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 258A, Sept

Comprehensive quantitative analysis of proteins co-dysregulated with overexpressing Her-2 cell lines using multi-range 2D-DIGE and mass spectrometry. Breast Cancer Research & Treatment 82(Supplement 1): S166

Comprehensive resource The cancer genome anatomy project. American Journal of Human Genetics 71(4 Supplement): 392, October

Comprehensive risk assessments of home environments of low-income, non-inner city preschool-aged children with asthma. Journal of Allergy & Clinical Immunology 113(2 Supplement): S230, February

Comprehensive screening for coding region microsatellite instability in colorectal cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 44: 307, July

Comprehensive screening for genes specifically expressed in Xenopus anterior neuroectoderm. Development Growth & Differentiation 43(Supplement): S41, July

Comprehensive screening for germ-line RB1 mutations by DHPLC and QMPSF. American Journal of Human Genetics 73(5): 253, November

Comprehensive screening of TOR1A gene in early-onset dystonia patients No evidence of allelic heterogeneity. American Journal of Human Genetics 67(4 Supplement 2): 372, October

Comprehensive screening of abused drugs in traffic accidents and trauma victims. Toxicology Letters (Shannon) 144(Suppl 1): s74, September

Comprehensive screening of the RYR1 gene by denaturing high-performance liquid chromatography. American Journal of Human Genetics 71(4 Supplement): 547, October

Comprehensive screening of the dystrophin gene. American Journal of Human Genetics 73(5): 412, November

Comprehensive screening using breast MRI and ductal lavage in high-risk women. Breast Cancer Research & Treatment 76(Supplement 1): S152, December

Comprehensive sequence analysis of a human 20Q132 breast cancer amplicon. Proceedings of the American Association for Cancer Research Annual Meeting (41): 725, March

Comprehensive sequence analysis ruled out disease association with the CFTR gene in a family with atypical CF presentations. American Journal of Human Genetics 73(5): 583, November

Comprehensive sequencing based typing strategies for HLA class I and II genes. European Journal of Immunogenetics 28(2): 340, April

Comprehensive setting of 30,000 polymorphic microsatellite markers throughout human genome. American Journal of Human Genetics 69(4 Supplement): 458, October

Comprehensive sibling donor cord blood banking for children with malignant and non-malignant disease. Blood 96(11 Part 1): 452a-453a, November 16

Comprehensive stress magnetic resonance imaging compared to stress echo in the evaluation of patients presenting to the emergency department with chest pain. Journal of the American College of Cardiology 43(5 Supplement A): 354A, March 3

Comprehensive structure - function analysis of humanin, a neuroprotective factor against Alzheimers disease relevant insults. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 526 4

Comprehensive study an vitamin C equivalent antioxidant capacity of various polyphenolics in scavenging a free radical and its structural relationship. Critical Reviews in Food Science & Nutrition 44(4): 253-273

Comprehensive study for the removal and retention of mercury from aqueous systems via a macroporous char. Abstracts of Papers American Chemical Society 223(1-2): ENVR 205

Comprehensive study of biodiesel fuel for HSDI engines in conventional and low temperature combustion conditions. Renewable Energy: 2, 368-378

Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients. Journal of Hepatology 40(Suppl 1): 93, April

Comprehensive study on dynamics of microbial community in Anaerobic-Oxic-Oxic process using PCR-DGGE, gas chromatography analysis, and dehydrogenase activity assays. World Journal Of Microbiology & Biotechnology: 2, 273-279

Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. Transplantation Proceedings 42(1): 39-41

Comprehensive survey of combinatorial library synthesis: 2001. Journal of Combinatorial Chemistry 4(5): 369-418

Comprehensive survey of developmental genes in the pea aphid, Acyrthosiphon pisum: frequent lineage-specific duplications and losses of developmental genes. Insect Molecular Biology 19 Suppl 2: 47-62

Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression. Clinical Pharmacokinetics 41(11): 853-876

Comprehensive system for theoretical drug design using in vitro, in vivo, and in silico experiments. Biophysical Journal 82(1 Part 2): 361a, January

Comprehensive thrombophilia profile in juvenile idiopathic stroke. Blood 94(10 SUPPL 1 PART 1): 242a, Nov 15

Comprehensive transcript analysis in small quantities of mRNA by SAGE-lite. Nucleic Acids Research 27(24): E39-E39

Comprehensive treatment of plantar wart. Journal of Shanghai Medical University 26(2): 156, March

Comprehensive treatment of social anxiety disorder. European Neuropsychopharmacology 10(Supplement 3): S187-S189, September

Comprehensive two-dimensional gas chromatography-mass spectrometry analysis of volatile constituents in Thai vetiver root oils obtained by using different extraction methods. Phytochemical Analysis 21(2): 163-173

Comprehensive urodynamic evaluation of 146 men with post-radical prostatectomy incontinence. Journal of Urology 167(4 Supplement): 199, April

Comprehensive vertigo management. Official Gazette of the United States Patent & Trademark Office Patents 1287(1), Oct 5

Comprehensive view of the assessment quality of the Austrian Animal Needs Index TGI 35 I/1995 for fattening pigs. Animal Welfare 13(Supplement): S252-S253, February

Comprehensive, homogeneous analysis of the MCAD gene. Journal of Inherited Metabolic Disease 26(Supplement 2): 188, September

Compress for medical treatment. Official Gazette of the United States Patent & Trademark Office Patents 1242(1), Jan 2

Compress garment facilitating the use of medical electrodes. Official Gazette of the United States Patent & Trademark Office Patents 1270(4), May 27

Compressed air massage, a new treatment modality?. Medicine & Science in Sports & Exercise 35(5 Supplement): S108, May

Compressed bale method. Official Gazette of the United States Patent & Trademark Office Patents 1271(3), June 17

Compressed bean composite and method therefore. Official Gazette of the United States Patent & Trademark Office Patents 1265(2), Dec 10

Compressed blends of coconut coir pith and a non-coir/non-peat materials, and processes for the production thereof. Official Gazette of the United States Patent & Trademark Office Patents 1259(4), June 25

Compressed chloramine-T tablets and method for the production thereof. Official Gazette of the United States Patent & Trademark Office Patents 1259(4), June 25

Compressed dry-granulation desogestrel tablets. Official Gazette of the United States Patent & Trademark Office Patents 1234(3), May 16

Compressed lecithin preparations. Official Gazette of the United States Patent & Trademark Office Patents 1252(1), Nov 6

Compressed loading apparatus and method for liquid transfer. Official Gazette of the United States Patent & Trademark Office Patents 1259(1), June 4

Compressed microparticles for dry injection. Official Gazette of the United States Patent & Trademark Office Patents 1274(5), Sep 30

Compressed nitroglycerin tablet and its method of manufacture. Official Gazette of the United States Patent & Trademark Office Patents 1265(5), Dec 31

Compressed-air powder inhaler. Official Gazette of the United States Patent & Trademark Office Patents 1231(5), Feb 29

Compressibility and density of select liquid and solid foods under pressures up to 700 MPa. Journal Of Food Engineering: 4, 568-574

Compressibility and thickness of supported lipid bilayers measured with an atomic force microscope. Society for Neuroscience Abstracts 26(1-2): Abstract No -800 7

Compressibility probe for monitoring blood volume changes. Official Gazette of the United States Patent & Trademark Office Patents 1264(4), Nov 26

Compressible atherectomy burr. Official Gazette of the United States Patent & Trademark Office Patents 1287(1), Oct 5